Medication-induced QT-interval prolongation and torsades de pointes: A turning point?

Website intended for a NZ health professional readership

+Practice

In print

PHARMACOTHERAPY

Medication-induced QT-interval prolongation and torsades de pointes: A turning point?

15 July 2020

By Pauline McQuoid

Wednesday 15 July 2020, 01:15 AM

Drug interactions can increase the risk of QTinterval prolongation

Medication-induced QT-interval prolongation is a serious issue because it can lead to potentially fatal torsades de pointes. This article reviews how you can assess the risk and avoid the problem in your patients

Pauline McQuoid

Key points, Medications are the most common cause of acquired QT-interval prolongation, which increases the risk of developing torsades de pointes. Many medical, Pract Green w Pale Yellow

Pharmacology

Medicines and Therapies

Clinical

Pharmacy

How to Treat

+How to treat

Heart failure

Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality

Wednesday 29 January 2025, 12:45 AM